Martine A Rothblatt sold $5.1M of UTHR
Chairperson & CEO at UNITED THERAPEUTICS Corp. 9,500 shares at an average of $534.31, traded Oct 8, 2026, filed Oct 9, 2026.
Score components
- +25RoleCEO
- +25Trade size$5.1M at market
- 0Share of holdings soldSold 2.8% of holdings
- +8Cluster2 insiders selling within 14 days
- -15Exercise and sellShares came from an option exercise in the same filing
- -2010b5-1 planPre-scheduled under a 10b5-1 plan
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001106578-26-000160, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Oct 8, 2026 | MOption exercise Common Stockindirect: by Trust10b5-1 | +9,500 | $117.76 | $1.1M | 333,943 | 2 d ago |
| Oct 8, 2026 | SOpen-market sale Common Stockindirect: by Trust10b5-1 | -200 | $525.50 | $105k | 333,743 | 2 d ago |
| Oct 8, 2026 | SOpen-market sale Common Stockindirect: by Trust10b5-1 | -767 | $526.66 | $404k | 332,976 | 2 d ago |
| Oct 8, 2026 | SOpen-market sale Common Stockindirect: by Trust10b5-1 | -273 | $527.57 | $144k | 332,703 | 2 d ago |
| Oct 8, 2026 | SOpen-market sale Common Stockindirect: by Trust10b5-1 | -200 | $528.63 | $106k | 332,503 | 2 d ago |
| Oct 8, 2026 | SOpen-market sale Common Stockindirect: by Trust10b5-1 | -199 | $530.13 | $105k | 332,304 | 2 d ago |
| Oct 8, 2026 | SOpen-market sale Common Stockindirect: by Trust10b5-1 | -1,061 | $531.07 | $563k | 331,243 | 2 d ago |
| Oct 8, 2026 | SOpen-market sale Common Stockindirect: by Trust10b5-1 | -600 | $532.07 | $319k | 330,643 | 2 d ago |
| Oct 8, 2026 | SOpen-market sale Common Stockindirect: by Trust10b5-1 | -800 | $533.36 | $427k | 329,843 | 2 d ago |
| Oct 8, 2026 | SOpen-market sale Common Stockindirect: by Trust10b5-1 | -920 | $534.28 | $492k | 328,923 | 2 d ago |
| Oct 8, 2026 | SOpen-market sale Common Stockindirect: by Trust10b5-1 | -480 | $535.46 | $257k | 328,443 | 2 d ago |
| Oct 8, 2026 | SOpen-market sale Common Stockindirect: by Trust10b5-1 | -824 | $536.61 | $442k | 327,619 | 2 d ago |
| Oct 8, 2026 | SOpen-market sale Common Stockindirect: by Trust10b5-1 | -1,016 | $537.53 | $546k | 326,603 | 2 d ago |
| Oct 8, 2026 | SOpen-market sale Common Stockindirect: by Trust10b5-1 | -605 | $538.60 | $326k | 325,998 | 2 d ago |
| Oct 8, 2026 | SOpen-market sale Common Stockindirect: by Trust10b5-1 | -1,091 | $539.58 | $589k | 324,907 | 2 d ago |
| Oct 8, 2026 | SOpen-market sale Common Stockindirect: by Trust10b5-1 | -424 | $540.51 | $229k | 324,483 | 2 d ago |
| Oct 8, 2026 | SOpen-market sale Common Stockindirect: by Trust10b5-1 | -40 | $541.23 | $22k | 324,443 | 2 d ago |
| Oct 8, 2026 | MOption exercise Stock Optionderivativeindirect: by Trust10b5-1 | -9,500 | $0.00 | $0 | 271,410 | 2 d ago |
Related signals
Other insiders at UNITED THERAPEUTICS Corp and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 23Weak | UNITED THERAPEUTICS Corp | Martine A Rothblatt Chairperson & CEO | $5.2M 9,500 shares | -3% | |
| 23Weak | UNITED THERAPEUTICS Corp | Martine A Rothblatt Chairperson & CEO | $5.1M 9,500 shares | -3% | |
| 23Weak | UNITED THERAPEUTICS Corp | Martine A Rothblatt Chairperson & CEO | $5.1M 9,500 shares | -3% | |
| 23Weak | UNITED THERAPEUTICS Corp | Martine A Rothblatt Chairperson & CEO | $5.2M 9,500 shares | -3% | |
| 23Weak | UNITED THERAPEUTICS Corp | Martine A Rothblatt Chairperson & CEO | $5.5M 9,500 shares | -3% | |
| 18Weak | UNITED THERAPEUTICS Corp | Paul A Mahon EVP & GENERAL COUNSEL | $4.7M 8,300 shares | -16% | |
| 23Weak | UNITED THERAPEUTICS Corp | Martine A Rothblatt Chairperson & CEO | $3.9M 7,580 shares | -2% | |
| 38Weak | UNITED THERAPEUTICS Corp | Martine A Rothblatt Chairperson & CEO | $1.1M 1,920 shares | -1% | |
| 23Weak | UNITED THERAPEUTICS Corp | Martine A Rothblatt Chairperson & CEO | $4.5M 9,500 shares | -3% | |
| 30Weak | UNITED THERAPEUTICS Corp | Martine A Rothblatt Chairperson & CEO | $4.6M 9,500 shares | -3% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.